Resources Hub
Search
Close this search box.
Logo Asphalion

COVID-19 UPDATE

Two days ago, EMA notified the start of a rolling review of data on the monoclonal antibody regdanvimab (Celltrion) for the treatment of COVID-19.

Two days ago, EMA notified the start of a rolling review of data on the monoclonal antibody regdanvimab (Celltrion) for the treatment of COVID-19.
February 26, 2021
| ,

Two days ago, EMA notified the start of a rolling review of data on the monoclonal antibody regdanvimab (Celltrion) for the treatment of COVID-19. These are great news, as now there are a total of 5 products being evaluated by EMA (3 vaccines and 2 treatments) which could be placed on the market during the following months, depending on the results of the evaluation.

The development of new tools to treat COVID-19 brings renewed hopes to fight against the pandemic. At Asphalion we are actively aiding in the development of vaccines and treatments for COVID-19, bringing our best to help all developers get their products ready to be authorized.

For further information you can contact us at: [email protected]

Search News & Events

  • Search

  • Filter by category

Share

Related news and events

AWARENESS | HUMAN RIGHTS DAY 2024

December 10, 2024

Today, we join the global community in commemorating Human Rights Day, a day of profound significance observed annually on 10 December, reflecting on the promise

EVENT | DIA RAPS Regulatory Policy Forum

December 4, 2024

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

More news & Events

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Logo Asphalion
Free Meeting

Services

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

Memberships & Partnerships

Catalonia Trade & Investment - ACCIÓ
Team PRRC
Veeva Certified Partner
Navarra Health Cluster
Cluster MAD eHealth

Quality Management System

Innovative SME

SDGs

Sustainable Development Goals - Logo

As a company committed to sustainability, we follow the UN’s 2030 Agenda and its Sustainable Development Goals.

© Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule Now!
Schedule a meeting